Rare disease therapy developer, Immusoft, has signed a licensing agreement with Takeda Pharmaceutical with a total potential value of more than $900 million, to discover, develop and commercialize transformative cell therapies in rare inherited metabolic disorders with...
Krispy Kreme begins trading under "DNUT" on the Nasdaq Global Select Market on Thursday, offering 29 million shares of its common stock at a public offering price of $17 per share — coming in far below industry estimates.
While the fashion industry reckons with female body image positivity, investors embraced plus-size retailer Torrid in its Wall Street debut Thursday.
Torrid, an apparel company for women who wear sizes 10 to 30, shares...
According to Lincoln Financial Group’s Monthly Consumer Sentiment Tracker, Asian Americans (37%) are most worried about lost income from layoffs and reduced employment hours as a result of COVID-19—a fear that is not unfounded in a population hit...
India is reportedly moving forward with a sweeping ban on cryptocurrencies. According to media reports, the country’s legislature will introduce a bill that criminalizes trading, mining, issuing, transferring, or possessing cryptocurrency. The bill is likely to pass if...
IronNet Cybersecurity announced on Monday that it will go public through a combination with LGL Systems Acquisition. The company leads a list of new SPAC IPO's.
Shares of Seneca Biopharma (NASDAQ:SNCA) are very active pre-market following their run Friday. While $SNCA stock closed at $1.64 during the regular session, shares climbed as high as $1.93 before the final...
More Americans are choosing to put their latest stimulus check money to work for them in the stock market, according to trading app Webull CEO Anthony Denier. Their actions are affecting the parabolic growth and valuations of...
Results from Zillow's Consumer Housing Trends Report show renters of color typically submit more applications — and pay more in application fees — before they secure...
A COVID-19 investigational vaccine, developed by City of Hope scientists and now licensed to GeoVax Labs Inc., produced a robust neutralizing antibody...
